Menu

Illumina, Inc. ILMN

Full chart Compare
Set alert

Price alert · ILMN

All alert types
214.91 USD -5.87 (-2.66%)

At closeNov 11, 2026, 7:32 AM EST

218.09 +3.18 +1.48%

Pre-market · Nov 11, 7:32 AM ET

212.00 Day range 220.83
112.65 52-week range 309.35
YTD
+63.85%
1 year
+76.56%

Discussion (32)

Sign in to join the discussion

Asahi Superdry ILMN 2 years ago #12

Slowly but surely…??one day you will be back to $200….new ceo doing great! im all in! Muacks ❤️… love you ILMN, …to the moon & back.

Asahi Superdry ILMN 3 years ago #14

Don’t buy yet.. This gonna fall to $80… the next resistance level.

VICKY HANUKA ILMN 3 years ago #15

$PTC Therapeutics(PTCT.US)$ ?????????????? Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics' Royalty on Evrysdi -- Royalty Pharma purchases a portion of royalties on Roche's Evrysdi for
$1.0 billion upfront
-- PTC Therapeutics has option to sell rest of royalty for up to $500
million; Royalty Pharma has option to buy half of rest of royalty for up
to $250 million
-- Transaction expected to enhance long-term Adjusted Cash Receipts growth
(non-GAAP)
-- Royalty Pharma to host conference call today, Thursday, October 19 at
9:00am EDT
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today an agreement with PTC Therapeutics, Inc. to acquire additional royalties on Roche's Evrysdi for $1.0 billion upfront. The agreement includes options for PTC to sell up to all of its retained royalties on Evrysdi for up to $500 million or for Royalty Pharma to acquire half of such retained royalties for up to $250 million at a later date.

Rey Pinoy ILMN 3 years ago #18

Sold going bad on July big layoff

Piloto ILMN 3 years ago #20

No. 2 bidder says its initial offer was double that of eventual winner Pfizer.